DIA/FDA Oligonucleotide-Based Therapeutics Conference

Investors

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Oct 28, 2019 2:30 PM EDT

James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “The emerging safety and activity of siRNA drugs using the TRIMTM platform”

Location

North Bethesda, MD